Nuwellis (NUWE) Competitors $0.99 +0.02 (+2.23%) Closing price 03/27/2025 03:53 PM EasternExtended Trading$1.01 +0.02 (+2.01%) As of 03/27/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUWE vs. XAIR, LFWD, DHAI, ALUR, NEPH, IRIX, NRXS, QTI, CODX, and INBSShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Beyond Air (XAIR), ReWalk Robotics (LFWD), DIH Holding US (DHAI), Allurion Technologies (ALUR), Nephros (NEPH), IRIDEX (IRIX), NeurAxis (NRXS), QT Imaging (QTI), Co-Diagnostics (CODX), and Intelligent Bio Solutions (INBS). These companies are all part of the "medical equipment" industry. Nuwellis vs. Beyond Air ReWalk Robotics DIH Holding US Allurion Technologies Nephros IRIDEX NeurAxis QT Imaging Co-Diagnostics Intelligent Bio Solutions Beyond Air (NASDAQ:XAIR) and Nuwellis (NASDAQ:NUWE) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk, analyst recommendations and community ranking. Do insiders & institutionals have more ownership in XAIR or NUWE? 31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 3.1% of Nuwellis shares are owned by institutional investors. 20.1% of Beyond Air shares are owned by company insiders. Comparatively, 2.6% of Nuwellis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation & earnings, XAIR or NUWE? Nuwellis has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeyond Air$3.02M6.40-$60.24M-$1.06-0.27Nuwellis$8.74M0.50-$20.21M-$38.53-0.03 Does the media prefer XAIR or NUWE? In the previous week, Beyond Air had 2 more articles in the media than Nuwellis. MarketBeat recorded 4 mentions for Beyond Air and 2 mentions for Nuwellis. Nuwellis' average media sentiment score of 1.43 beat Beyond Air's score of 0.99 indicating that Nuwellis is being referred to more favorably in the news media. Company Overall Sentiment Beyond Air Positive Nuwellis Positive Does the MarketBeat Community believe in XAIR or NUWE? Beyond Air received 26 more outperform votes than Nuwellis when rated by MarketBeat users. Likewise, 69.57% of users gave Beyond Air an outperform vote while only 53.66% of users gave Nuwellis an outperform vote. CompanyUnderperformOutperformBeyond AirOutperform Votes4869.57% Underperform Votes2130.43% NuwellisOutperform Votes2253.66% Underperform Votes1946.34% Which has more risk & volatility, XAIR or NUWE? Beyond Air has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500. Do analysts prefer XAIR or NUWE? Beyond Air presently has a consensus price target of $3.67, indicating a potential upside of 1,204.40%. Nuwellis has a consensus price target of $17.00, indicating a potential upside of 1,617.00%. Given Nuwellis' stronger consensus rating and higher possible upside, analysts plainly believe Nuwellis is more favorable than Beyond Air.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Nuwellis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Is XAIR or NUWE more profitable? Nuwellis has a net margin of -169.54% compared to Beyond Air's net margin of -1,730.00%. Beyond Air's return on equity of -226.01% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Beyond Air-1,730.00% -226.01% -109.75% Nuwellis -169.54%-28,159.25%-207.24% SummaryBeyond Air beats Nuwellis on 10 of the 18 factors compared between the two stocks. Remove Ads Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUWE vs. The Competition Export to ExcelMetricNuwellisElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.33M$3.25B$5.64B$8.06BDividend YieldN/A1.63%4.57%4.01%P/E Ratio-0.0114.8923.1319.03Price / Sales0.5042.73383.8993.17Price / CashN/A44.0938.1634.64Price / Book0.053.456.944.33Net Income-$20.21M$89.74M$3.20B$247.06M7 Day Performance-12.38%-1.19%-2.33%-0.37%1 Month Performance-20.79%-10.48%2.84%-3.85%1 Year Performance-92.04%-19.34%10.75%1.27% Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUWENuwellis3.6635 of 5 stars$0.99+2.2%$17.00+1,617.0%-92.8%$4.33M$8.74M-0.0170Short Interest ↓XAIRBeyond Air4.5857 of 5 stars$0.28+5.6%$3.67+1,194.3%-83.8%$19.49M$3.02M-0.2770LFWDReWalk Robotics2.4646 of 5 stars$1.80+4.7%$9.00+400.0%-63.7%$19.13M$25.66M-0.7260Short Interest ↑DHAIDIH Holding US1.2102 of 5 stars$0.32-17.8%N/A-76.2%$18.60M$64.47M-1.08N/AShort Interest ↓High Trading VolumeALURAllurion Technologies2.3464 of 5 stars$3.43-4.2%$22.83+565.7%-92.6%$17.16M$34.75M-0.29501Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageHigh Trading VolumeNEPHNephros2.0902 of 5 stars$1.60+2.9%$5.00+213.5%-28.3%$16.82M$14.16M-17.7230Earnings ReportShort Interest ↑IRIXIRIDEX1.2617 of 5 stars$0.95-4.0%$2.00+110.5%-70.1%$15.80M$48.43M-1.42120Earnings ReportAnalyst ForecastHigh Trading VolumeNRXSNeurAxisN/A$2.19-5.2%N/A-37.1%$15.71M$2.46M-1.1919Gap DownQTIQT ImagingN/A$0.55-8.3%N/A-44.1%$14.92M$4.00M0.00N/APositive NewsGap DownCODXCo-Diagnostics3.8063 of 5 stars$0.46+0.6%$1.50+223.6%-64.9%$14.80M$7.32M-0.34100Earnings ReportNews CoverageINBSIntelligent Bio Solutions0.4522 of 5 stars$2.11-2.3%N/A-64.9%$14.30M$3.03M0.0010News Coverage Remove Ads Related Companies and Tools Related Companies XAIR Alternatives LFWD Alternatives DHAI Alternatives ALUR Alternatives NEPH Alternatives IRIX Alternatives NRXS Alternatives QTI Alternatives CODX Alternatives INBS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUWE) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.